Comparison of an Isotonic Balanced Fluid, Sterofundin® , With 0.9% Saline in Traumatic Brain Injury(TBI) (FLUID)
Primary Purpose
Brain Injuries
Status
Unknown status
Phase
Not Applicable
Locations
Malaysia
Study Type
Interventional
Intervention
Sterofundin
0.9% saline
Sponsored by
About this trial
This is an interventional treatment trial for Brain Injuries focused on measuring Traumatic brain injury, isotonic balanced fluid
Eligibility Criteria
Inclusion Criteria:
- Patients age between 18 and 65 years of age
- Non-penetrating moderate (GCS 9-12) or severe (GCS 3-8) traumatic brain injury
- Within 12 hours since the recorded time of injury
Exclusion Criteria:
- Pregnancy
- Polytrauma
- Cardiac arrest at presentation
- GCS of three with bilateral fixed dilated pupils,
- Evidence of severe cardiac, respiratory, renal or liver dysfunction
Sites / Locations
- University of Malaya Medical Centre
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Strerofundin
0.9% saline
Arm Description
Days of intervention: 3 days
Days of intervention: 3 days
Outcomes
Primary Outcome Measures
30 day mortality
Functional neurological outcomes at 6 months based on Extended Glasgow Outcome Scale (GOS-E)
Secondary Outcome Measures
Acid-base balance
through out intervention period
Daily mean change in intracranial pressure (ICP)
through out intervention period
Episodes of intracranial hypertension
through out intervention period
Duration of mechanical ventilation
through out intervention period
Length of ICU stay
through out intervention period
electrolyte balance
ICU mortality
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02866604
Brief Title
Comparison of an Isotonic Balanced Fluid, Sterofundin® , With 0.9% Saline in Traumatic Brain Injury(TBI)
Acronym
FLUID
Official Title
Comparison of an Isotonic Balanced Fluid, Sterofundin® , With 0.9% Saline in Traumatic Brain Injury(TBI)
Study Type
Interventional
2. Study Status
Record Verification Date
October 2016
Overall Recruitment Status
Unknown status
Study Start Date
October 2016 (undefined)
Primary Completion Date
August 2018 (Anticipated)
Study Completion Date
February 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Malaya
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The main objective of this study is to compare the clinical outcomes of TBI patients receiving only Sterofundin or 0.9% saline as main fluid therapy.
Detailed Description
Study Design: Prospective single centre double-blind randomized controlled trial
Study endpoints/outcomes
Primary outcomes:
30 day mortality
Functional neurological outcomes at 6 months based on Extended Glasgow Outcome Scale (GOS-E)
Secondary outcomes:
Acid-base and electrolyte balance
Daily mean change in intracranial pressure (ICP)
Episodes of intracranial hypertension
Duration of mechanical ventilation
Length of ICU stay and ICU mortality
Study Duration: 2 years Site: UMMC. Departments involved: Emergency Medicine, Surgery, Anaesthesiology and Pharmacy
Methodology. Investigators will assess patients admitted to the Emergency Department, UMMC, for eligibility.
Randomisation:
Investigators will randomize patients in a 1:1 ratio to either 0.9% saline intravenous fluid group or Sterofundin® intravenous fluid group. An independent statistician not involved with the research will perform a block of eight randomisation using computerised number generator list.
Conduct of study The Department of Pharmacy will identically seal all 0.9% saline and Sterofundin® intravenous fluid bottles and label them, according to their type, as either A or B. The patients, investigators and medical and nursing staff will not be aware of the designation of the letters A and B to the fluids.
Investigators will administer the study fluid will immediately after patient randomisation and this will last for 72 hours.
Other general care of the traumatic brain injury patients from both study arms will continue as per Neurosurgical Unit protocol and Brain Trauma Foundation guidelines.
Data handling
Investigators will collect all data relevant to both primary and secondary outcomes (see also attached proforma):
Statistical analysis Investigators will conduct students t test, Chi squared and the Mann-Whitney U test as appropriate. Investigators will adjust results with univariable and multivariable logistic regression and report their odds ratio. Investigators will present survival analysis using Kaplan Meier curves and compare them using log rank test.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Brain Injuries
Keywords
Traumatic brain injury, isotonic balanced fluid
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
160 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Strerofundin
Arm Type
Active Comparator
Arm Description
Days of intervention: 3 days
Arm Title
0.9% saline
Arm Type
Active Comparator
Arm Description
Days of intervention: 3 days
Intervention Type
Procedure
Intervention Name(s)
Sterofundin
Intervention Type
Procedure
Intervention Name(s)
0.9% saline
Primary Outcome Measure Information:
Title
30 day mortality
Time Frame
30 days
Title
Functional neurological outcomes at 6 months based on Extended Glasgow Outcome Scale (GOS-E)
Time Frame
180 days
Secondary Outcome Measure Information:
Title
Acid-base balance
Description
through out intervention period
Time Frame
3 days
Title
Daily mean change in intracranial pressure (ICP)
Description
through out intervention period
Time Frame
3 days
Title
Episodes of intracranial hypertension
Description
through out intervention period
Time Frame
3 days
Title
Duration of mechanical ventilation
Description
through out intervention period
Time Frame
3 days
Title
Length of ICU stay
Description
through out intervention period
Time Frame
30 days
Title
electrolyte balance
Time Frame
3 days
Title
ICU mortality
Time Frame
30 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients age between 18 and 65 years of age
Non-penetrating moderate (GCS 9-12) or severe (GCS 3-8) traumatic brain injury
Within 12 hours since the recorded time of injury
Exclusion Criteria:
Pregnancy
Polytrauma
Cardiac arrest at presentation
GCS of three with bilateral fixed dilated pupils,
Evidence of severe cardiac, respiratory, renal or liver dysfunction
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sia S Fu, MSurg, PhD
Phone
+603-79492441
Email
sfsia02@um.edu.my
Facility Information:
Facility Name
University of Malaya Medical Centre
City
Petaling Jaya
State/Province
Wilayah Persekutuan Kuala Lumpur
ZIP/Postal Code
50603
Country
Malaysia
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Sia S Fung, MSurg, PhD
Phone
+603-79492441
Email
sfsia02@um.edu.my
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Comparison of an Isotonic Balanced Fluid, Sterofundin® , With 0.9% Saline in Traumatic Brain Injury(TBI)
We'll reach out to this number within 24 hrs